There are a number of errors in [Table 3](#pone.0223545.t001){ref-type="table"}. The value in column 7 \"% points\" for the line "LDN x 4+" in the group "All examined medicines" should be -3.3, not 0. Additionally, the p-values in the ninth column "P" are incorrect. Please see the correct [Table 3](#pone.0223545.t001){ref-type="table"} here.

10.1371/journal.pone.0223545.t001

###### The number of users of examined medicines among patients with rheumatoid and seropositive arthritis one year before and after the first dispense of LDN.

![](pone.0223545.t001){#pone.0223545.t001g}

                                            Number of users   Difference                                            
  ---------------------------- ------------ ----------------- ------------ ----- -------- ------- ----------------- -------
  **All examined medicines**   LDN x 1      104               (99.0)       100   (95.2)   -3.8    (-7.5 to -0.2)    0.048
                               LDN x 2--3   70                (93.3)       73    (97.3)   4.0     (-1.8 to 9.8)     0.184
                               LDN x 4+     170               (94.4)       164   (91.1)   -3.3    (-7.7 to 1.0)     0.135
  **DMARD**                    LDN x 1      70                (66.7)       69    (65.7)   -1.0    (-9.1 to 7.2)     0.819
                               LDN x 2--3   44                (58.7)       48    (64.0)   5.3     (-3.6 to 14.3)    0.252
                               LDN x 4+     94                (52.2)       82    (45.6)   -6.7    (-12.3 to -1.0)   0.025
  **NSAIDs**                   LDN x 1      73                (69.5)       63    (60.0)   -9.5    (-18.1 to -1.0)   0.035
                               LDN x 2--3   53                (70.7)       47    (62.7)   -8.0    (-18.3 to 2.3)    0.138
                               LDN x 4+     121               (67.2)       114   (63.3)   -3.9    (-10.5 to 2.7)    0.251
  **Analgesics**               LDN x 1      79                (75.2)       80    (76.2)   1.0     (-5.2 to 7.1)     0.764
                               LDN x 2--3   55                (73.3)       58    (77.3)   4.0     (-7.4 to 15.4)    0.493
                               LDN x 4+     115               (63.9)       107   (59.4)   -4.4    (-10.4 to 1.5)    0.146
  **Corticosteroids**          LDN x 1      53                (50.5)       53    (50.5)   0.0     (-9.1 to 9.1)     1.000
                               LDN x 2--3   25                (33.3)       25    (33.3)   0.0     (-11.1 to 11.1)   1.000
                               LDN x 4+     62                (34.4)       54    (30.0)   -4.4    (-10.6 to 1.7)    0.159
  **TNF-α antagonists**        LDN x 1      15                (14.3)       12    (11.4)   -2.9    (-7.8 to 2.1)     0.259
                               LDN x 2--3   9                 (12.0)       11    (14.7)   2.7     (-2.5 to 7.9)     0.321
                               LDN x 4+     22                (12.2)       17    (9.4)    -2.8    (-5.2 to -0.4)    0.027
  **Other DMARDs**             LDN x 1      42                (40.0)       39    (37.1)   -2.9    (-10.5 to 4.8)    0.468
                               LDN x 2--3   29                (38.7)       31    (41.3)   2.7     (-5.6 to 10.9)    0.529
                               LDN x 4+     57                (31.7)       45    (25.0)   -6.7    (-10.3 to -3.0)   0.001
  **Opioids**                  LDN x 1      54                (51.4)       55    (52.4)   1.0     (-6.7 to 8.7)     0.809
                               LDN x 2--3   42                (56.0)       39    (52.0)   -4.0    (-15.4 to 7.4)    0.493
                               LDN x 4+     77                (42.8)       57    (31.7)   -11.1   (-19.0 to -3.3)   0.007
  **Other analgesics**         LDN x 1      60                (57.1)       64    (61.0)   3.8     (-2.1 to 9.7)     0.209
                               LDN x 2--3   36                (48.0)       43    (57.3)   9.3     (-1.2 to 19.9)    0.094
                               LDN x 4+     88                (48.9)       85    (47.2)   -1.7    (-7.1 to 3.8)     0.549

LDN, low dose naltrexone. DMARD, disease-modifying antirheumatic drug. NSAID, a non-steroid anti-inflammatory drug. Three groups based on number of LDN dispenses: LDN ×1 (*N* = 105) collected LDN once, LDN ×2--3 (*N* = 75) two or three times and LDN ×4+ (*N* = 180) four or more times. Other DMARDs include methotrexate, antimalarials, aminosalicylates and leflunomide. DMARDs is the sum of TNF-α antagonists, systemic corticosteroids and other DMARDs. Other analgesics include paracetamol/acetaminophen and other non-opioid analgesics.

There are a number of errors in [S2 Table](#pone.0223545.s001){ref-type="supplementary-material"}. The p-values in the ninth column "P" are incorrect. Please view the correct [S2 Table](#pone.0223545.s001){ref-type="supplementary-material"} below.
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###### The number of users of medicines classified as Other DMARDs among patients with rheumatoid and seropositive arthritis one year before and after the first dispense of LDN.

(PDF)

###### 

Click here for additional data file.
